Show Description +
J. Fernando Arevalo, MD, summarizes his discussion on time from intravitreal bevacizumab (Avastin, Genentech) injection to vitrectomy in cases of severe proliferative diabetic retinopathy (PDR). He provides important data from his group's collaboration with other groups.
Posted: 1/25/2017
J. Fernando Arevalo, MD, summarizes his discussion on time from intravitreal bevacizumab (Avastin, Genentech) injection to vitrectomy in cases of severe proliferative diabetic retinopathy (PDR). He provides important data from his group's collaboration with other groups.
Posted: 1/25/2017
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of RWC: 2017.
Please log in to leave a comment.